Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research

News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971

Poseida, Legend/Janssen Look To Snag Celgene/Bluebird's BCMA Crown

Mon, 12/03/2018 - 9:15pm

Poseida and Legend/Janssen aim to develop CAR-T therapies with improved efficacy and safety, and both programs delivered updates at ASH...

      Related Stories 

CVS CEO Larry Merlo On What Comes Next After Aetna Merger

Mon, 12/03/2018 - 11:54am

One day after CVS' $70bn acquisition of Aetna closed, CEO Larry Merlo spoke at the Forbes Healthcare Summit about why...

      Related Stories 

Pharma Told To Get It Right First Time On Clinical Trial Data

Mon, 12/03/2018 - 5:28am

Drug companies are complying with their obligation to submit clinical trial results to the US-based database, but major errors in their...

      Related Stories 

What’s Under The Iceberg: GE Healthcare’s Deep Dive Look At Future Of Gene Therapy

Mon, 12/03/2018 - 4:12am

Cell and gene therapy represent a transformative advance in drug delivery and outcomes, with implications equally as important to human...

      Related Stories 

Pipeline Watch: Phase III Starts With PRN1008, JZP-258 And Nolasiban

Mon, 12/03/2018 - 1:26am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical...

      Related Stories 

VIDEO: Alligator CEO Discusses Pipeline Additions, Milestone Expectations And The IO Deal Landscape

Mon, 12/03/2018 - 1:21am

Alligator Bioscience’s Per Norlen discusses the latest addition to its pipeline, a first-in-class bispecific tumor-localized antibody targeting the checkpoint inhibitor...

      Related Stories 

More Vaccines Restructuring As Daiichi's Oncology Pivot Gains Momentum

Sun, 12/02/2018 - 8:26pm

Daiichi Sankyo makes further vaccine business restructuring moves as it emphasizes oncology amid global generic challenges to its former big...

      Related Stories 

'Totality Of Data' Make A Case For Luspatercept In Beta-Thalassemia, MDS

Sun, 12/02/2018 - 7:04pm

Acceleron/Celgene’s drug was effective across all endpoints in transfusion-dependent beta-thalassemia and myelodysplastic syndromes, but Acceleron CEO Habib Dable notes key...

      Related Stories 

Analysts Weigh Up Benefits Of Big Bayer Restructuring

Fri, 11/30/2018 - 6:32am

The investment community has praised Bayer's bosses for a "much-needed shake-up and slimming down of the organisation" as management increases...

      Related Stories 

Medical Aesthetics: A Untapped Pharma Market With Incoming Competition

Fri, 11/30/2018 - 12:12am

Medical aesthetics is a unique biopharmaceutical niche that may scare off companies due to the consumer marketing and doctor relationship-building...

      Related Stories 

What's Keeping Korea From Becoming A Digital Healthcare Power?

Thu, 11/29/2018 - 10:33pm

While digital healthcare start-ups are increasingly being established in South Korea, strict regulations and a limited market environment are keeping...

      Related Stories 

Is Alkermes’ Schizophrenia Data Enough To Drive Demand?

Thu, 11/29/2018 - 1:57pm

Alkermes showed that combo pill ALKS 3831 offers a better weight gain profile compared to olanzapine in schizophrenia patients, but...

      Related Stories 

No, It's Not Just Out-Of-Pocket Costs That Are A Problem, John Arnold Tells Pharma

Thu, 11/29/2018 - 1:51pm

The billionaire philanthropist and industry agitator took the stage at the Forbes Healthcare Summit to discuss why his foundation is...

      Related Stories